The Influence of Internet + Combined Family Empowerment Management Mode on Treatment Compliance of PATIENTS With CKD
1 other identifier
observational
100
1 country
1
Brief Summary
To explore the effect of Internet + combined family empowerment management mode on treatment compliance of patients with chronic kidney disease (CKD) and the correlation between psychological status and disease progression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2023
CompletedFirst Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2024
CompletedDecember 22, 2023
December 1, 2023
8 months
December 4, 2023
December 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
blood urea nitrogen
5ml of fasting elbow vein was collected from patients in the morning at four study observation time points from T1 to T4, and Z206A table top medical centrifuge produced by HERMLE, Germany, was centrifuged at a speed of 1500 r/min for 0.5h to extract upper serum, which was placed in a refrigerator at -70℃ for detection.
70/5000 The four observation time points in this study were 1 day before treatment, 1 month, 3 months, and 6 months after treatment, labeled T1 to T4, respectively. T1 ~ T4 when fasting in the morning.
serum creatinine
5ml of fasting elbow vein was collected from patients in the morning at four study observation time points from T1 to T4, and Z206A table top medical centrifuge produced by HERMLE, Germany, was centrifuged at a speed of 1500 r/min for 0.5h to extract upper serum, which was placed in a refrigerator at -70℃ for detection.
70/5000 The four observation time points in this study were 1 day before treatment, 1 month, 3 months, and 6 months after treatment, labeled T1 to T4, respectively. T1 ~ T4 when fasting in the morning.
Secondary Outcomes (3)
Morisky Medication Adherence Scale
Six months Max
General Self-Efficacy Scale
Six months Max
Self-Rating Anxiety Scale
Six months Max
Study Arms (2)
combined group
traditional group
Interventions
indoor temperature and humidity adjustment, regular ventilation and hygiene of ward and clinic environment, promotion of patients' health awareness by distributing disease brochures, regular inspection of wards, and home nursing and health guidance based on disease knowledge when discharged
The specific measures were as follows :(1) intervention group construction. (2) Online knowledge promotion. (3) Disease assessment.(4) Medication guidance reminder.(5) Enabling psychological counseling.
Eligibility Criteria
Combined with laboratory results, CKD was confirmed
You may qualify if:
- Enrolled subjects meet the diagnostic criteria for CKD and are confirmed to be CKD based on laboratory findings.
- After assessment, it was determined that the subject's communication was barrier-free
- No abnormal feedback was found after evaluation.
- The patient received dialysis treatment for more than 3 months, and the clinical data were complete. This is the first time they've been to the hospital.
You may not qualify if:
- The female patient is pregnant and lactating.
- Kidney transplant patient.
- People with language communication disorders or mental diseases.
- Participants received other psychological guidance and health education interventions during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 4, 2023
First Posted
December 12, 2023
Study Start
November 23, 2023
Primary Completion
July 24, 2024
Study Completion
November 24, 2024
Last Updated
December 22, 2023
Record last verified: 2023-12